Literature DB >> 36050581

A review of the components of exercise prescription for sarcopenic older adults.

Prabal Kumar1, Shashikiran Umakanth2, N Girish3.   

Abstract

PURPOSE: To synthesize the details of the exercises/exercise program prescribed for the improvement of muscle mass/muscle strength/physical performance among sarcopenic older adults.
METHODS: A systematic literature search was conducted in five electronic databases and the details of exercises such as single component or multicomponent exercise program, frequency/week, intensity, duration of the exercise program, type of exercises, progression, adverse events reported, outcome measures used, and whether technology or other educational aids were used to deliver the program were extracted.
RESULTS: A total of 10,045 records were identified and 27 records were included. Resistance exercises were included in all the studies, with the frequency ranging from 1 to 5/week, intensity ranging from 20 to 80% of 1 repetition maximum (RM), or 6-14 points on ratings of perceived exertion (RPE), and duration per session ranging from 20 to 75 min. The intensity of aerobic exercises ranged from 50 to 70% of heart rate max or a level of 7-17 in RPE with a duration ranging from 6 to 30 min per session for 2-5 days/week. For balance exercises, the intensity was mentioned as the level of effort 3 on a scale of 10, and the time duration per session ranged from 5 to 30 min for a frequency of 2/3 per week.
CONCLUSION: This review synthesized the components of exercise prescription for sarcopenic older adults which would help practitioners and researchers in selecting the frequency, intensity, duration, type, mode, and progression while prescribing exercises.
© 2022. The Author(s).

Entities:  

Keywords:  Exercise; Older adults; Resistance; Sarcopenia

Year:  2022        PMID: 36050581     DOI: 10.1007/s41999-022-00693-7

Source DB:  PubMed          Journal:  Eur Geriatr Med        ISSN: 1878-7649            Impact factor:   3.269


  41 in total

Review 1.  Sarcopenia and frailty in chronic respiratory disease.

Authors:  Anna E Bone; Nilay Hepgul; Samantha Kon; Matthew Maddocks
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

Review 2.  Sarcopenia.

Authors:  Anne Tournadre; Gaelle Vial; Frédéric Capel; Martin Soubrier; Yves Boirie
Journal:  Joint Bone Spine       Date:  2018-08-08       Impact factor: 4.929

3.  Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.

Authors:  Liang-Kung Chen; Jean Woo; Prasert Assantachai; Tung-Wai Auyeung; Ming-Yueh Chou; Katsuya Iijima; Hak Chul Jang; Lin Kang; Miji Kim; Sunyoung Kim; Taro Kojima; Masafumi Kuzuya; Jenny S W Lee; Sang Yoon Lee; Wei-Ju Lee; Yunhwan Lee; Chih-Kuang Liang; Jae-Young Lim; Wee Shiong Lim; Li-Ning Peng; Ken Sugimoto; Tomoki Tanaka; Chang Won Won; Minoru Yamada; Teimei Zhang; Masahiro Akishita; Hidenori Arai
Journal:  J Am Med Dir Assoc       Date:  2020-02-04       Impact factor: 4.669

Review 4.  Association Between Sarcopenia and Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Ke-Vin Chang; Tsai-Hsuan Hsu; Wei-Ting Wu; Kuo-Chin Huang; Der-Sheng Han
Journal:  J Am Med Dir Assoc       Date:  2016-11-02       Impact factor: 4.669

Review 5.  Sarcopenia: origins and clinical relevance.

Authors:  I H Rosenberg
Journal:  J Nutr       Date:  1997-05       Impact factor: 4.798

Review 6.  Sarcopenia and its implications for the elderly.

Authors:  R Roubenoff
Journal:  Eur J Clin Nutr       Date:  2000-06       Impact factor: 4.016

7.  Differences in the Prevalence of Sarcopenia in Community-Dwelling, Nursing Home and Hospitalized Individuals. A Systematic Review and Meta-Analysis.

Authors:  S K Papadopoulou; P Tsintavis; P Potsaki; D Papandreou
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

8.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

Review 9.  Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS).

Authors:  Alfonso J Cruz-Jentoft; Francesco Landi; Stéphane M Schneider; Clemente Zúñiga; Hidenori Arai; Yves Boirie; Liang-Kung Chen; Roger A Fielding; Finbarr C Martin; Jean-Pierre Michel; Cornel Sieber; Jeffrey R Stout; Stephanie A Studenski; Bruno Vellas; Jean Woo; Mauro Zamboni; Tommy Cederholm
Journal:  Age Ageing       Date:  2014-09-21       Impact factor: 10.668

10.  Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions.

Authors:  Charlotte Beaudart; Médéa Locquet; Jean-Yves Reginster; Laura Delandsheere; Jean Petermans; Olivier Bruyère
Journal:  Aging Clin Exp Res       Date:  2017-12-01       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.